drugset / Trial / NCT05883150

Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment

NCT05883150

Phase 2/3 Completed 68 enrolled Nourhan M.Aly
RandomizedParallel-groupSingle-blindSupportive care

Summary

The aim of the current study is to compare the effect of intranasal versus nebulized route of administration of midazolam as moderate sedative agents in preschoolers undergoing dental treatment.

Timeline

Start
2022-11-10
Primary completion
2023-08-30
Completion
2023-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule Other

Indications

No indication recorded.